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httpcense.Abstract Purpose: To emphasis the role of cardiac magnetic resonance compared to echocardiog-
raphy in evaluating patients with ischemic cardiomyopathy to accurately assess global and regional
Left ventricular function which is essential for prognosis and for evaluating therapeutic responses.
Methods and materials: The studied group included 37 patients already diagnosed as having ische-
mic cardiomyopathy. All patients were subjected to full history taking and radiological evaluation
using a 1.5-T MR system and echocardiography. Comparison was made between echocardiography
and cardiac magnetic resonance regarding segmental wall motion by using the 17-segment model of
the American Heart Association. Agreement regarding segmental wall motion was assessed by
using Cohen’s Kappa statistics. Also ejection fraction measurement by both modalities was com-
pared. Detection of transmural extent of myocardial scar was also performed.
Results: Poor agreement between cardiac magnetic resonance and echocardiography regarding seg-
mental wall motion with Cohen’s Kappa is 0.195, P value of <0.001. Mean ejection fraction by
cardiac magnetic resonance was 33.3% and mean ejection fraction by echocardiography was
29% with a mean difference of 4.3%.
Conclusion: Cardiac magnetic resonance is superior to echo in evaluating segmental wall motion abnor-
malitywith echounderestimating segmentalwallmotionabnormality yet nearly similar ejection fractionval-
ues by both modalities were achieved. Moreover, cardiac magnetic resonance is better in evaluating
associated cardiac abnormalities as well as extracardiac ﬁndings due to its higher spatial resolution. In addi-
tion, cardiacmagnetic resonance is used inmyocardial viability assessment in the same settingwhich if com-
binedwith segmental wallmotion abnormality can lend a hand in evaluating the cardiac contractile reserve.
 2013 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine.Open access under CC BY-NC-ND license.1468004.
(A.S. Ibrahim).
tian Society of Radiology and
g by Elsevier
ing by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear Medicine.
://dx.doi.org/10.1016/j.ejrnm.2013.06.004
476 R.S. Hussein et al.1. Introduction
Cardiomyopathy is deﬁned as a myocardial disorder in which
there is structural and functional abnormality of the cardiac
muscle (1). Ischemic cardiomyopathy is an end result of severe
coronary artery disease (CAD) whereas ischemic etiology of
cardiomyopathy is deﬁned as the presence of any epicardial
coronary vessels with signiﬁcant stenosis (more than 50%) or
any history of myocardial infarction (MI) or coronary revascu-
larization (either percutaneous transluminal coronary angio-
plasty ‘‘PTCA’’ or coronary artery bypass grafting
‘‘CABG’’) (2).
To date, cardiac function could be assessed with various
noninvasive modalities, such as echocardiography, nuclear
medicine, multidetector computed tomography (MDCT), and
magnetic resonance (MR) imaging (3).
Cardiac magnetic resonance (CMR) imaging is a non inva-
sive technique that is considered the reference standard for the
measurement of global ventricular quantitative parameters, as
well as for regional qualitative wall motion assessment, be-
cause of its high accuracy (4). Accurate assessment of left ven-
tricular ejection fraction (EF) is essential for prognosis and
evaluating therapeutic responses in patients with ischemic car-
diomyopathy (5).
The aim of this study was to emphasise the role of CMR in
the evaluation of patients with ischemic cardiomyopathy to as-
sess myocardial viability and accurate assessment of LV func-
tion at both regional and global levels.2. Materials and methods
2.1. Study population
Over a period of 24 months, from July 2010 till June 2012,
CMR study was performed for 37 patients (34 male and 3 fe-
males; their mean age was 56.4 (+/7.7) with known ischemic
cardiomyopathy based on clinical symptoms and documented
LV dysfunction by echocardiography or history of coronary
artery bypass grafting (CABG) (seven patients), percutaneous
coronary intervention (PCI) (16 patients) or myocardial infarc-
tion (15 patients). LV dysfunction was deﬁned as an LV ejec-
tion fraction less than or equal to 45%. One of the patients
presented with acute ischemia, two were in a subacute state
and the rest were chronic ischemic cases. The study was done
in the Ain Shams University Hospital and specialized private
center in Cairo. The study was performed after approval of
the Ethical committee of scientiﬁc Research, faculty of medi-
cine, Ain Shams University and after taking consent from all
patients.
2.2. MR imaging protocol
The study was performed at both sites on an identical 1.5-T
MR system (Gyroscan Intera CV and Achiva; Philips Medical
Systems, Best, the Netherlands). Localizer sequences in three
orthogonal planes were taken followed by standard cardiac
2-, 3-, and 4-chamber views as well as short axis (SA) cine
images in steady state free precession (SSFP). All images were
acquired using a phased-array 16 channel cardiac coil during
single breath-holds (end expiratory of about 9–13 s) withECG gating. Acquisition parameters for 2-, 3- and 4-chambers
views were: repetition time msec/echo time msec, 3.14/1.69; ﬂip
angle, 55; pixel size, 1.8 · 2.3 mm; Field of view (FOV),
320 mm2; matrix, 192. SA acquisition parameters were: repeti-
tion time msec/echo time msec, 3/1.52; ﬂip angle, 55; section
thickness, 8 mm; gap, 5 mm; pixel size, 1.8 · 2.3 mm; Field
of view (FOV), 380 mm2; matrix, 280.
Contrast media was injected of about 0.2 mmol/kg body
weight with acquisition of real-time retrospective gated dy-
namic cine SA view in three slices in free breathing fashion
(at rest). Then, late gadolinium enhancement (LGE) images
were obtained 10 min after the injection of the contrast mate-
rial using an inversion recovery (IR) sequence. Imaging of left
ventricle was from base to the apex and the acquisition was
performed in SA view and additionally in a four chamber view.
Images were acquired during end-expiration breath hold.
Acquisition parameters of IR sequence are Repetition time
msec/echo time msec, 6.1/3; section thickness, 5 mm; gap,
0 mm; Field of view (FOV), 361 mm2; matrix, 224; TI, variable
for every patient.
2.3. Echo imaging protocol
Echo imaging was performed by a ﬁve-year experienced cardi-
ologist on a Toshiba Aplio XV ultrasound machine with a
transducer of 2.5–4.0 MHz. Images were obtained in short
axis, 4- and 2-chamber views. Two to three cardiac cycles were
obtained for the assessment of segmental wall motion at apex,
mid cavity and base of left ventricle. EF was calculated by
modiﬁed Simpson’s rule via 4- and 2-chamber planimetry of
the left ventricle.
3. Data processing for MRI
3.1. Functional image analysis
Short axis CINE images were transferred to the off-line work-
station (extended work space ‘‘EWS’’); Pride software (Philips
Medical Systems). Delineation of endo- and epicardial con-
tours of left ventricle at end-diastole and end-systole gives glo-
bal functional parameters (EF). Regional function was also
assessed either qualitatively (described as normal, hypokinetic,
akinetic, or dyskinetic) or quantitatively (relative or absolute
wall thickening) using the 17-segment model of the American
Heart Association (AHA).
3.2. Viability analysis
Visual assessment of the presence of scar tissue and its extent
across the myocardial wall was performed. Transmural extent
of infarction can be expressed as follows: 1–25% of left-ven-
tricular wall thickness or 26–50% of LV wall thickness or
51–75% LV wall thickness and 76–100% of LV wall thickness.
3.3. Statistical methods
Statistical analysis was done on a personal computer using
MedCalc version 12.1.0.0 (MedCalc Software, Mari-
akerke, Belgium). Agreement between segmental wall motion
by MRI and ECHO was examined using Cohen’s kappa
Table 2 Results of Bland–Altman plot for agreement between
echocardiography and MRI as regards estimation of ejection
fraction.
Measure Value
EF by echocardiography (%) 33.3 (8.2)
EF by MRI (%) 29 (10)
Bias* 4.29
SD of bias 6.73
95% Limits of Agreement 8.90–17.5
EF is expressed as mean (SD).
* Bias = average of differences.
 95% Limits of Agreement = bias plus or minus 1.96 times SD.
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was assessed by a 4-point scale (1, normal; 2, hypokinesia;
3, akinesia; 4, dyskinesia) in a per segment analysis (with
the 17-segment model).
To examine agreement between EF in MRI and ECHO,
Bland–Altman plots were used. To determine the diagnostic
value of MRI, a series of 2 · 2 contingency tables were con-
structed to contrast the examination tool of interest (CMR)
to standard reference tool (ECHO) as regards left atrial
(LA) enlargement, left ventricular (LV) enlargement, wall
thinning, intracavitary thrombus and valvular lesions. Then
Negative predictive values (NPV) as well as 95% CI were
obtained.
4. Results
The study was performed on thirty-seven patients, their mean
age was 56.4(+/7.7), thirty-four were males and three pa-
tients were females, 26 patients (70.3%) were hypertensive,
15 patients (40.5%) were diabetic, 22 patients (59.5%) were
smokers, 16 patients (43.2%) had previous PCI, 7 patients
(18.9%) had previous CABG.
Per-segment agreement between echocardiography and
MRI as regards the detection of segmental wall motion abnor-
mality in the 629 segments examined in the 37 patients. Poor
agreement was noted using Cohen’s Kappa (r) is 0.195, SE
of r is 0.031, P value of <0.001 (Table 1). Concordant seg-
ments between MRI and ECHO were as follows: 120 segments
(19.1%) of 629 segments showing no motion abnormality by
two modalities, 140 segments (22.3%) showing hypokinesia,
39 segments (6.2%) showing akinesia, and 4 segments (0.6%)
showing dyskinesia.
Agreement between Echocardiography and MRI for the
estimation of ejection fraction (EF) was noted. Among 37 pa-
tients, the mean EF by MRI was 33.3% and the mean EF by
echocardiography was 29% with a mean difference of 4.3%.
SD of bias was of 6.73 and 95% limits of agreement were
8.90–7.5 (Table 2 & Fig. 1).
MRI had an imperative role in the diagnosis of other car-
diac abnormalities – using echocardiography as the referenceTable 1 Per-segment agreement between echocardiography and MR
the 629 segments examined in 37 patients.
SWMA by echo
Normal
SWMA by MRI
Normal Count 120
% of Total 19.1%
Hypokinesia Count 82
% of Total 13.0%
Akinesia Count 17
% of Total 2.7%
Dyskinesia Count 1
% of Total 0.2%
Total Count 220
% of Total 35.0%standard. MRI showed a NPV of 87.5% for the evaluation
of the left ventricle (LV) enlargement, for left atrial (LA)
enlargement of NPV was 80.95%, LV wall thinning was 0%
(Fig. 2), LV cavitary thrombus was 96.87% (Figs. 3 and 4)
and as for valvular lesions (Fig. 4), NPV was 92.59%
(Table 3).
Regarding extent of myocardial scar tissue by late gadolin-
ium enhancement (LGE): study revealed out of 629 analyzed
segments in 37 patients, 2 segments showed 1–25% transmural
extent of infarction of myocardial walls, 50 segments showed
26–50% transmural extent of infarction, 5 segments showed
51–70% transmural extent of infarction and 178 segments
showed 71–100% transmural extent of infarction. Also 394
segments showed no enhancing scar tissue.
To predict the contractile reserve in our 37 patients, ter-
ritorial assessment of segmental wall motion abnormality
(SWMA) using MRI associated with scar tissue was com-
pared to that of echocardiography for the prediction of myo-
cardial scar in the collectively three vascular territories
(LAD, LCX & RCA). As for MRI, this showed 87 territo-
ries of 111 territories with SWMA, whereas 59 of them
showed scar by LGE and 28 showed no scar. Twenty-four
segments showed no SWMA whereas only two of them
showed scar by MRI. As for echocardiography, this showed
86 territories of 111 territories with SWMA, whereas 54 ofI as regards detection of segmental wall motion abnormality in
Hypokinesia Akinesia Dyskinesia Total
70 16 0 206
11.1% 2.5% 0% 32.8%
140 53 0 275
22.3% 8.4% 0% 43.7%
75 39 0 131
11.9% 6.2% 0% 20.8%
11 1 4 17
1.7% 0.2% 0.6% 2.7%
296 109 4 629
47.1% 17.3% 0.6% 100.0%
Fig. 1 Bland–Altman plot for agreement between echocardiog-
raphy and MRI for the estimation of ejection fraction.
Fig. 2 A 53 year old male patient with a past history of coronary ste
dypsnea. A. SSFP in 4 chamber view revealed biatrial and biventricular
in diastole revealed thinning of the interventricular septum & posterior
reduced being 19% on the left and 11.8% on the right. Delayed enhan
chamber views (G) revealed transmural infarction following LAD territ
also noted more advanced basally (black arrow).
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ﬁve segments showed no SWMA whereas seven of them
showed scar by MRI. So, SWMA by MRI associated with
scar tissue showed a sensitivity of 96.72% with 95% CI of
88.65–99.6% and NPV of 91.67% while by echo showed
88.52% with 95% CI of 77.78–95.26% and 72.00% respec-
tively (Table 4).
In three patients; CMR was superior to echocardiography
in detecting extra cardiac manifestations where one showed
mildly dilated ascending aorta measuring 37 mm, one
showed extensive bilateral bronchopneumonic changes with
bilateral pleural effusion and the later showed bilateral pleu-
ral effusion. These ﬁndings were not seen by
echocardiography.
Three patients of 37 patients had microvascular occlusion
(MVO) that was seen on dynamic and LGE images. These
no re ﬂow areas appeared hypointense compared to the rest
of the myocardium.
5. Discussion
Patients with ischemic cardiomyopathy have many treatment
options that are tailored according to every patient. These in-
clude revascularization (CABG or PCI), medical therapy or re-
cent techniques including cell transplantation or even cardiac
transplant. So, viability assessment is crucial to identify patients
who have dysfunctional yet viable myocardium from those hav-
ing a non viable myocardium. This is used to recognize patients
who will beneﬁt from revascularization and avoid exposure tonting and known ischemic heart disease presented with progressive
chamber dilatation. SSFP in short axis views (B) in systole and (C)
wall (arrowed) with global hypokinesia. Both ventricular EF were
cement inversion recovery (IR) sequences in short axis (E,F) & 4
ory (arrow heads), subendocardial infarction of LCX territory was
Fig. 3 A 50 year old male patient with known ischemic heart disease presented with progressive dyspnea and chest tightness. Past history
of MI occurred few years ago. SSFP in 4 chamber (A), short axis (B) & 3 chamber views (C) revealed intraluminal mass lesion seen within
left lateral ventricle near the apex (white arrow). Delayed enhancement inversion recovery (IR) sequence in 4 chamber (D), short axis (E)
and 2 chamber views (F) revealed transmural infarction of apex, anterior wall, antroseptal and postroseptal walls (following LAD
territory). Absence of enhancement of the intraventricular mass conﬁrmed its thrombotic origin.
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imaging modalities are available to assess dysfunctional yet via-
blemyocardium; these include echocardiography, single photon
emission computed tomography (SPECT) imaging, positron
emission tomography (PET) and CMR (6).
From the most important predictors of myocardial viability
is regional contractility at rest. The aim of different treatment
strategies is to preserve the contractile function of heart (7).
Thus, CMR is a single non invasive procedure that can assess
LV function and EF (5) as well as identifying myocardial
infarction as either acute or chronic (8). Myocardial function
can be assessed by CMR and echocardiography. The latter is
the most widely used technique for evaluating LV function.
Its advantages include easy performance as a bedside rapid
screening tool, no exposure of the patients to radiation and
its cheap cost (9). However, its disadvantages are difﬁculties
in deﬁning endocardial contours in patients with limited image
quality with poor echo imaging window where this is especially
seen in patients having advanced pulmonary disease, high
body mass index, and those who have undergone thoracic sur-
gery. So, echo cannot evaluate SWMA in all patients (10).
In this study, agreement between echo and MRI regarding
SWMA was poor with Cohen’s Kappa is 0.195, SE of j is
0.031, P value of <0.001. Gardner et al., (11) found moder-
ately good correlations between CMR and transthoracic echo
regarding SWMA where there was underestimation of SWMA
by echo compared to CMR denoting that CMR is more sensi-
tive in differentiating diseased from normal myocardium. In a
study performed by Ku¨hl et al., (10); the authors found that
agreement between echo and MRI regarding SWMA was
moderate (r= 0.47) with echo showing signiﬁcantly lowermean scores than MR imaging. Yang et al., (12) also compared
2D-echo with gradient-echo CMR for the evaluation of
SWMA in patients with good and poor echo image quality.
The authors found good agreement (r= 0.79) regarding
SWMA depiction between echo and CMR imaging in the pa-
tients with good echo image quality. As regards patients with
poor echo image quality, MR imaging was superior for the
visualization of wall segments.
In this study, mean EF by MRI was 33.3% and mean EF
by echocardiography is 29% with a mean difference of 4.3%.
Our ﬁnding agreed with Hoffmann et al., (13) who stated that
the mean differences between EF deﬁned by echocardiography
images and EF by MRI were below 5%. Dewey et al., (9) men-
tioned that EF comparisons of non contrast 2D Echo with
MRI were fairly accurate for assessment with limits of agree-
ment of 21.2% which do not agree with our study. Gardner
et al. (11) found that LVEF correlated moderately well be-
tween MRI and echocardiography. However, echo underesti-
mated LVEF compared to CMR by 4 percentage points.
This also agrees with our study.
Grover et al., (14) stated that CMR is highly superior to
2D-echocardiography when examining global LV function
and is better for follow-up without cumulative radiation expo-
sure. Its accuracy in the evaluation of function makes it the ref-
erence standard for all imaging modalities. Myocardial
viability is assessed by CMR by late gadolinium enhancement
(LGE) (14). This is performed 10–20 min after contrast injec-
tion utilizing inversion-recovery gradient echo sequences with
the inversion time set to null viable myocardium. Infarcted
zone appears as an area of bright signal (hyperenhancement)
in LGE images being typically, in ischemic condition,
Fig. 4 A 60 year old male patient with known ischemic heart disease presented with progressive dyspnea and chest tightness. Past history
of PCI that was done 2 years ago. SSFP in 4 chamber (A) and short axis (B) views show enlarged left and right ventricles. SSFP in short
axis view, (C) in systole and (D) in diastole revealed global hypokinesia. (E) SSFP in 2 chamber view shows apical thrombus (white
arrows) as well as mitral regurge appearing in the form of black jet within left atria (black arrow head). Delayed enhancement inversion
recovery (IR) sequence in short axis (F and G) and 4 chamber (H) views show apical and mid anterior, anterolateral & septal transmural
infarction with apical non enhancing thrombus (arrows).
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depending on the extent of the infarct (15). In this study, out
of the 629 segments studied in 37 patients, we found that
two segments showed 1–25% transmural extent of infarction
of myocardial walls, 50 segments showed 26–50% transmural
extent of infarction, ﬁve segments showed 51–70% transmuralextent of infarction and 178 segments showed 71–100% trans-
mural extent of infarction. Also 394 segments showed no
enhancing scar tissue. In a study by Hillenbrand et al., (16),
it was found that when the segmental transmural extent of
hyperenhancement was <25%, the majority (87%) of seg-
ments showed improved function, whereas when the extent
Table 3 Value of MRI for the diagnosis of other cardiac abnormalities using echocardiography as reference standard.
LA enlargement LV enlargement Wall thinning LV Cavitary thrombus Valvular lesions
Negative Predictive Value (NPV) 80.95% 87.50% 0.00% 96.87% 92.59%
95% CI 58.09–94.55% 61.65–98.45% 0.00–17.65% 83.78–99.92% 75.71–99.09%
Table 4 Diagnostic value of SWMA identiﬁed with MRI and
echo for the prediction of myocardial scar as diagnosed with
MRI in the collectively three vascular territories in the 37
patients which could predict the contractile reserve.
SWMA by MRI SWMA by ECHO
Sensitivity 96.72% 88.52%
95% CI 88.65–99.6% 77.78–95.26%
Negative Predictive
Value (NPV)
91.67% 72.00%
95% CI 73–98.97% 50.61–87.93%
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likely, with intermediate degrees of hyperenhancement result-
ing in intermediate likelihood of recovery.
In this study, detected SMWA by MRI by territory for pre-
diction of scar tissue by MRI for the assessment of contractile
reserve in collectively the three vascular territories in the 37 pa-
tients showed 87 territories of 111 territories with SWMA,
whereas 59 of them showed scar by LGE and 28 showed no
scar. Twenty-four segments showed no SWMA whereas only
two of them showed scar by MRI. So, sensitivity of 96.72%
with 95% CI of 88.65–99.6% and NPV of 91.67% were calcu-
lated. O¨zben et al., (17) stated that combining LGE and seg-
mental wall motions assessment by CINE MRI yields better
information about contractile reserve. In another study by
Gerber et al., (18), it was found that segments showing trans-
mural hyper enhancement had no signiﬁcant inotropic reserve
when assessed with low-dose dobutamine-tagged MRI, and
non transmural hyper enhancement showed contractile re-
serve, consistent with residual viability. In this study, we de-
tected SMWA by echocardiography for the prediction of
scar tissue by MRI showing 86 territories of 111 territories
with SWMA whereas 54 of them showed scar by LGE and
32 showed no scar. Twenty-ﬁve segments showed no SWMA
whereas only seven of them showed scar by MRI. So, sensitiv-
ity of 88.52% with 95% CI of 77.78–95.26% and NPV of 72%
were calculated. So, generally the evaluation of SWMA by
echocardiography at rest in combination with LGE MRI can
give an idea about contractile reserve. Although this will be
more accurate if we use CMR instead of echo for SWMA
detection.
We tried in this study, to evaluate other beneﬁts of CMR
over echocardiography in the detection of complications asso-
ciated with ischemic cardiomyopathy: diagnosis of left atrial
(LA) enlargement by MRI using echocardiography as refer-
ence standard; we detected LA enlargement in 16 (43.2%) pa-
tients. However, echocardiography only detected 9 (24.3%) of
them with suggested 4 (10.8%) additional LA enlargement
proved to be normal by MRI. By MRI; we detected LV
enlargement in 21 (56.8%) patients. However, echocardiogra-
phy only detected 13 (35.1%) of them with suggested 2(5.4%) additional LV enlargement proved to be normal by
MRI. Also, by MRI we detected thinning of myocardial walls
in 18 (48.6%) patients of the 37 with no corresponding detec-
tion of this thinning by echocardiography noted (Fig. 2). Five
patients (13.5%) had LV thrombus on MRI which was not
appreciated by echocardiography (Figs. 3 and 4). While one
patient was suspected to have LV thrombus by echocardiogra-
phy, revealed to be free by MRI. Also CMR helped in the eval-
uation of extra cardiac pathologies seen in three patients; one
showed mildly dilated ascending aorta measuring 37 mm, one
showed extensive bilateral bronchopneumonic changes with
bilateral pleural effusion and the latter showed bilateral pleural
effusion. These ﬁndings were not seen by echocardiography. In
a recent study done by Wyttenbach et al., (19) they found 250
incidental extra cardiac ﬁndings (ECF) in 401 patients per-
forming CMRmainly for ischemic causes. Eighty-four patients
(34%) had potentially signiﬁcant ECF including bronchial car-
cinoma, lung consolidation and abdominal abnormalities and
in the rest of the 166 (41%) non-signiﬁcant ECF were detected.
Hypoenhancement, which is seen 1–2 min after contrast
injection, deﬁnes areas of microvascular occlusion (MVO) or
no-reﬂow areas. The high spatial resolution of contrast cardiac
MRI allows identiﬁcation of these hypoenhanced areas. This is
of high clinical signiﬁcance as MVO area is associated with
poor patient’s prognosis and higher incidence of complications
(17). In our study, three patients of 37 had MVO appreciated
on dynamic and persist on LGE images as a zone of non
enhancement in acute and subacute ischemic states.
New techniques (T1 and T2 mappings) allow direct quanti-
ﬁcation of changes in myocardial signal intensity on a voxel-
by-voxel level (20). T2-weighted imaging shows high sensitivity
in the detection of acute infarct associated edema (14). T1-
mapping is a novel, quantitative method that is used for detect-
ing acute myocardial edema. Its high diagnostic performance
compared to dark-blood and bright-blood T2W-CMR, holds
the potential to quantify both extent and severity of disease
(21).
6. Conclusion
Due to its excellent spatial resolution, CMR provides high-
quality morphological images of the heart throughout the car-
diac cycle, allowing global and regional functional analysis as
well as direct visualization of the scar tissue by LGE.
On comparing the results of CMR and echocardiography
regarding global LV functional (EF), high concordance be-
tween the two modalities was noted with mean difference of
4.3%.
However, as regards regional functional analysis by CINE
MRI, poor agreement between CMR and echocardiography
in viewing SWMA was detected. Compared to other studies,
we concluded that CMR is superior to echo in evaluating
SWMA.
482 R.S. Hussein et al.Also using CMR can provide excellent spatial resolution as
regards morphological appearance of cardiac chambers, wall
thinning, intralumial thrombi as well as concomitant valvular
lesions. So, CMR was proved to be superior to echocardiogra-
phy in functional and morphological evaluations. Moreover,
CMR is better and superior in the evaluation of extra cardiac
pathologies e.g. pleural effusion, bronchopneumonia and asso-
ciated vascular lesions in major vessels.
LGE can provide foremost information about myocardial
viability as well as in evaluating the transmural extent of a myo-
cardial scar. Furthermore, a combination of LGE and SWMA
can lend a hand in evaluating the cardiac contractile reserve.Acknowledgments
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